# Matrix Partners China

> Matrix Partners China is a VC fund backing Health Care and Software. See 504 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 504
- Last investment: Aug 2026
- Lead investor: 34%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/matrix-partners/
- X (Twitter): https://www.twitter.com/matrixpartners
- Website: https://www.matrixpartners.com.cn/

Matrix Partners China is a VC fund in Beijing focused on Health Care and Software. Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

## Contacts

5 contacts available for Matrix Partners China. Shizune tracks 15 team members at Matrix Partners China. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/matrix-partners-china?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.8M–$98M |
| Series A | $3M–$61M |
| Series B | $10M–$137M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 49 | 10% |
| Software | 41 | 8% |
| Artificial Intelligence | 38 | 8% |
| Biotechnology | 37 | 7% |
| Information Technology | 37 | 7% |

275 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 144 | 29% |
| Series B | 117 | 23% |
| Seed | 64 | 13% |
| Series C | 48 | 10% |
| Angel | 32 | 6% |

15 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 303 | 60% |
| United States | 31 | 6% |
| Singapore | 7 | 1% |
| Hong Kong | 4 | 1% |
| India | 2 | 0% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Eric YU | Partner, Head of Healthcare | 8 | https://shizune.co/investors/profile/eric-yu-2 |
| Guoxiong Cao | Partner (RMB Funds) | 1 | https://shizune.co/investors/profile/guoxiong-cao |
| Kevin Xiong | Partner | 2 | https://shizune.co/investors/profile/kevin-xiong |
| Mi Zhou | Director | 0 | https://shizune.co/investors/profile/mi-zhou |
| Bo Shao | Founding Managing Partner | 16 | https://shizune.co/investors/profile/bo-shao |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aureka Biotechnologies | Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness. | $100M | Series B | Aug 10, 2026 |  |
| PoShell Robotics | PoShell Robotics is a general-purpose home robot, aiming to create a home-friendly and structurally stable robot. | $100M | Seed | Aug 03, 2026 |  |
| Tiiny AI | Tiiny AI offers a ready-to-use open-source ecosystem with one-click installation for models. |  | Angel | Jul 30, 2026 |  |
| Meshy AI | The #1 3D GenAI platform—trusted by millions worldwide. The ONLY 3D AI tool featured in A16Z's 2024 AI Tools Survey. | $400M | Series B | Jul 20, 2026 |  |
| RoboParty | RoboParty is a bipedal robot technology company that specializes in research, development, and engineering of humanoid robots. | $73.9M | Seed | Jul 15, 2026 |  |
| Shanghai Xinqi Robotics | Shanghai Xinqi Robotics is a high-tech enterprise specializing in the research and development of humanoid robots, focusing on creating advanced robotic technologies that enhance human-machine interaction, intelligent automation, and real-world applications across industries such as manufacturing, healthcare, education, and service robotics. |  | Series A | Jul 13, 2026 |  |
| ENN Energy Research Institute | ENN develops technologies and conducts research focused on sustainable energy solutions. The company works on proton-boron fusion, compact fusion systems, and other advanced energy generation approaches. Its services include designing experimental fusion reactors, modeling plasma behavior, and developing computational tools for energy simulations.ENN also engages in partnerships with universities, research institutes, and industry organizations to advance innovation in energy science. The company supports efforts to create scalable, low-carbon energy technologies and to explore applications in electricity generation and related scientific research. |  | Seed | Jul 10, 2026 |  |
| ENN Fusion | ENN Fusion is a commercialization company that specializes in research and commercial application of spherical cyclic hydrogen-boron fusion technology. |  | Seed | Jul 10, 2026 |  |
| Logicbit Technology | Logic Bit is a developer of large-scale superconducting quantum computing devices. Logic Bit has established technological reserves that encompass the full process of superconducting quantum chip design, micro-nano processing, radio frequency control, quantum computation, and simulation. |  | Series A | Jul 09, 2026 |  |
| Lingjing Zhiyuan | Lingjing Zhiyuan is an intelligence technology platform that develops full-stack embodied intelligence compute infrastructure and operating systems for robots. | $14.7M | Angel | Jul 08, 2026 |  |

10 of 504 investments shown.

## Co-investors
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 30 deals together
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund, 30 deals together
- [Source Code Capital](https://shizune.co/investors/profile/source-code-capital) — VC Fund, 27 deals together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 21 deals together
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund, 20 deals together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 19 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [All Investors in Asia](https://shizune.co/investors/investors-asia)
- [All VC Funds in Asia](https://shizune.co/investors/vc-funds-asia)
- [All Investors in China](https://shizune.co/investors/investors-china)
- [All VC Funds in China](https://shizune.co/investors/vc-funds-china)
- [SaaS Investors in Asia](https://shizune.co/investors/saas-investors-asia)
- [SaaS VC Funds in Asia](https://shizune.co/investors/saas-vc-funds-asia)

## FAQ

### What does Matrix Partners China invest in?

Matrix Partners China invests primarily in Health Care, Software and Artificial Intelligence startups, most often at Series A and Series B stage. Most of the 504 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Matrix Partners China's check size?

Matrix Partners China typically joins rounds of $2.8M–$98M at Seed, $3M–$61M at Series A and $10M–$137M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Matrix Partners China participates in.

### How do I contact Matrix Partners China?

Public channels for Matrix Partners China include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Matrix Partners China?

The team at Matrix Partners China includes Eric YU (Partner, Head of Healthcare), Guoxiong Cao (Partner (RMB Funds)) and Kevin Xiong (Partner), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co